Canada Markets open in 3 mins

Aurora Cannabis Inc. (ACB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.8400+0.4200 (+17.36%)
At close: 04:00PM EDT
2.8500 +0.01 (+0.35%)
Pre-Market: 09:27AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close2.4200
Open2.4300
Bid2.8000 x 36900
Ask2.8300 x 36200
Day's Range2.3900 - 2.8400
52 Week Range2.2000 - 10.6400
Volume10,413,862
Avg. Volume7,266,288
Market Cap563.098M
Beta (5Y Monthly)3.10
PE Ratio (TTM)N/A
EPS (TTM)-2.5090
Earnings DateFeb 09, 2022 - Feb 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.67
  • Motley Fool

    Why Aurora Cannabis, Canopy, and Sundial Stocks Popped on Friday

    Canadian cannabis company Aurora Cannabis (NASDAQ: ACB) reported its fiscal third-quarter 2022 earnings last night, and in so doing, sparked a rally across the cannabis sector today. As of 1 p.m. ET, shares of Aurora Cannabis itself are already up 13%, and peer producers Canopy Growth (NASDAQ: CGC) and Sundial Growers (NASDAQ: SNDL) are benefiting as well -- up 8.5% and 5.9%, respectively. Heading into Q3, analysts had forecast that Aurora Cannabis would lose $0.19 per share (0.25 Canadian dollars, and furthermore, this was a pro forma prediction) on sales of $41.5 million -- about CA$53.7 million.

  • Motley Fool

    Aurora Cannabis Inc. (ACB) Q3 2022 Earnings Call Transcript

    With me today are CEO, Miguel Martin; and CFO, Glen Ibbott. Listeners are also reminded that certain matters discussed in today's conference call could constitute forward-looking statements that are subject to risks and uncertainties related to our future financial or business performance.

  • The Canadian Press

    Aurora Cannabis posts $1-billion net loss in Q3, will close some facilities

    Aurora Cannabis Inc. reported several impairment charges and a more than $1-billion net loss in its most recent quarter Thursday as it revealed plans to close several facilities and cope with pricing pressures that ate into revenues already hampered by the COVID-19 pandemic. The third-quarter loss the Edmonton-based cannabis business reported was up from a more than $160 million loss in the same quarter last year and was coupled with $741.7 million in goodwill impairment charges and $176.1 milli